famotidine has been researched along with Cytomegalic Inclusion Disease in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshinaga, M | 1 |
| Nakate, S | 1 |
| Motomura, S | 1 |
| Sugimura, T | 1 |
| Sasaki, I | 1 |
| Tsuneyoshi, M | 1 |
1 other study available for famotidine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Cytomegalovirus-associated gastric ulcerations in a normal host.
Topics: Adult; Cytomegalovirus Infections; Famotidine; Humans; Inclusion Bodies, Viral; Male; Stomach; Stoma | 1994 |